Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 1
1975 6
1976 7
1977 6
1978 11
1979 6
1980 17
1981 16
1982 14
1983 34
1984 20
1985 24
1986 30
1987 30
1988 46
1989 49
1990 54
1991 47
1992 51
1993 45
1994 52
1995 58
1996 74
1997 75
1998 78
1999 92
2000 82
2001 104
2002 108
2003 114
2004 117
2005 131
2006 136
2007 153
2008 148
2009 166
2010 193
2011 227
2012 273
2013 273
2014 243
2015 261
2016 197
2017 141
2018 229
2019 202
2020 222
2021 211
2022 221
2023 199
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

4,769 results

Results by year

Filters applied: . Clear all
Page 1
Aberrant gut-microbiota-immune-brain axis development in premature neonates with brain damage.
Seki D, Mayer M, Hausmann B, Pjevac P, Giordano V, Goeral K, Unterasinger L, Klebermaß-Schrehof K, De Paepe K, Van de Wiele T, Spittler A, Kasprian G, Warth B, Berger A, Berry D, Wisgrill L. Seki D, et al. Among authors: giordano v. Cell Host Microbe. 2021 Oct 13;29(10):1558-1572.e6. doi: 10.1016/j.chom.2021.08.004. Epub 2021 Sep 3. Cell Host Microbe. 2021. PMID: 34480872 Free PMC article.
We found that maturation of electrocortical activity is suppressed in infants with severe brain damage. This is accompanied by elevated gammadelta T cell levels and increased T cell secretion of vascular endothelial growth factor and reduced secretion of neuroprotec …
We found that maturation of electrocortical activity is suppressed in infants with severe brain damage. This is accompanied by elevated gamm …
Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia.
Saygin C, Giordano G, Shimamoto K, Eisfelder B, Thomas-Toth A, Venkataraman G, Ananthanarayanan V, Vincent TL, DuVall A, Patel AA, Chen Y, Tan F, Anthony SP, Chen Y, Shen Y, Odenike O, Teachey DT, Kee BL, LaBelle J, Stock W. Saygin C, et al. Among authors: giordano g. Clin Cancer Res. 2023 Aug 15;29(16):3151-3161. doi: 10.1158/1078-0432.CCR-23-0415. Clin Cancer Res. 2023. PMID: 37363966 Free PMC article.
PURPOSE: Relapsed T-acute lymphoblastic leukemia (T-ALL) has limited treatment options. ...RESULTS: Typical T-ALL cells had increased dependence on BCL-xL, whereas early T-precursor (ETP)-ALL cells had higher BCL-2 dependence for survival. ...
PURPOSE: Relapsed T-acute lymphoblastic leukemia (T-ALL) has limited treatment options. ...RESULTS: Typical T-ALL cells …
CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma.
Gambella M, Carlomagno S, Raiola AM, Giannoni L, Ghiggi C, Setti C, Giordano C, Luchetti S, Serio A, Bo A, Falco M, Della Chiesa M, Angelucci E, Sivori S. Gambella M, et al. Among authors: giordano c. Front Immunol. 2022 Feb 24;13:837457. doi: 10.3389/fimmu.2022.837457. eCollection 2022. Front Immunol. 2022. PMID: 35280988 Free PMC article. Review.
These cancer immunotherapies are aimed to support or harness the patient's immune system to recognize and destroy cancer cells. Preclinical and clinical studies, based on the use of T cells and more recently NK cells genetically modified with chimeric antigen receptors ret …
These cancer immunotherapies are aimed to support or harness the patient's immune system to recognize and destroy cancer cells. Preclinical …
Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation.
Derrien J, Gastineau S, Frigout A, Giordano N, Cherkaoui M, Gaborit V, Boinon R, Douillard E, Devic M, Magrangeas F, Moreau P, Minvielle S, Touzeau C, Letouzé E. Derrien J, et al. Among authors: giordano n. Nat Cancer. 2023 Nov;4(11):1536-1543. doi: 10.1038/s43018-023-00625-9. Epub 2023 Aug 31. Nat Cancer. 2023. PMID: 37653140
Risk HLA Variants Affect the T-Cell Repertoire in Multiple Sclerosis.
Sorosina M, Santoro S, Ferrè L, Mascia E, Clarelli F, Giordano A, Cannizzaro M, Lucia M, Martinelli V, Filippi M, Esposito F. Sorosina M, et al. Among authors: giordano a. Neurol Neuroimmunol Neuroinflamm. 2023 Feb 15;10(3):e200093. doi: 10.1212/NXI.0000000000200093. Print 2023 May. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 36792371 Free PMC article.
T-cell repertoire features including diversity, public clones, and architecture were evaluated. ...DISCUSSION: Our study supports the association between MHC-risk alleles and macrofeatures of the T-cell repertoire in the context of MS. Further studies are needed to …
T-cell repertoire features including diversity, public clones, and architecture were evaluated. ...DISCUSSION: Our study supports the …
CDK9: A key player in cancer and other diseases.
Franco LC, Morales F, Boffo S, Giordano A. Franco LC, et al. Among authors: giordano a. J Cell Biochem. 2018 Feb;119(2):1273-1284. doi: 10.1002/jcb.26293. Epub 2017 Oct 5. J Cell Biochem. 2018. PMID: 28722178 Review.
Galectins in hematological malignancies.
Giordano M, Croci DO, Rabinovich GA. Giordano M, et al. Curr Opin Hematol. 2013 Jul;20(4):327-35. doi: 10.1097/MOH.0b013e328362370f. Curr Opin Hematol. 2013. PMID: 23695449 Review.
Functional studies have assigned a key role for galectin-1 as a negative regulator of T-cell immunity in Hodgkin's lymphoma and cutaneous T-cell lymphoma. ...
Functional studies have assigned a key role for galectin-1 as a negative regulator of T-cell immunity in Hodgkin's lymphoma and cutan …
Vascular-induced compensatory pseudo-retrocollis.
Giordano A, Tedeschi G, Tessitore A. Giordano A, et al. Neurology. 2015 May 12;84(19):2005-6. doi: 10.1212/WNL.0000000000001568. Neurology. 2015. PMID: 25964480 No abstract available.
What we may learn - and need - from pandemic fiction.
Doherty J, Giordano J. Doherty J, et al. Among authors: giordano j. Philos Ethics Humanit Med. 2020 Jul 21;15(1):4. doi: 10.1186/s13010-020-00089-0. Philos Ethics Humanit Med. 2020. PMID: 32690053 Free PMC article.
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy.
Chiriaco C, Donini C, Cortese M, Ughetto S, Modica C, Martinelli I, Proment A, Vitali L, Fontani L, Casucci M, Comoglio PM, Giordano S, Sangiolo D, Leuci V, Vigna E. Chiriaco C, et al. Among authors: giordano s. J Exp Clin Cancer Res. 2022 Oct 21;41(1):309. doi: 10.1186/s13046-022-02479-y. J Exp Clin Cancer Res. 2022. PMID: 36271379 Free PMC article.
RESULTS: We proved that MET-CAR-T exerted a specific cytotoxic activity against MET expressing cells. ...Notably, MET-CAR-T cells were also able to brake acquired resistance to MET targeting agents in MET amplified cancer cells carrying secondary mutations in downst …
RESULTS: We proved that MET-CAR-T exerted a specific cytotoxic activity against MET expressing cells. ...Notably, MET-CAR-T ce …
4,769 results